K-numberK250058
Device nameNEAT 001
ApplicantBrain Electrophysiology Laboratory Company, LLC
Product codeOLZ
Device classClass II
Decision dateApr 10, 2025
DecisionSubstantially Equivalent
Regulation882.1400
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

NEAT 001 is software that automatically scores sleep stages from EEG data according to American Academy of Sleep Medicine definitions. It is a client-server application using machine learning to analyze forehead EEG signals and classify sleep stages (Wake, REM, N1, N2, N3) for adult populations in physician offices or home settings.

Technological characteristics

NEAT is a software-only Class II device using machine learning on a single forehead EEG signal, similar to the predicate EnsoSleep. Both devices automatically score the same five sleep stages and produce sleep statistics. NEAT differs by not detecting leg movements or sleep disordered breathing events, which EnsoSleep does. NEAT's architecture uses a client-server model with Docker containerization, while the predicate uses a software-as-a-service cloud model.

Test standards cited

AAMI/ANSI/IEC 62304 Standard was applied with Class B safety classification. FDA Guidance on 'Content of Premarket Submissions for Software Contained in Medical Device' was followed. Performance evaluation used bootstrapped resampling (2000 resamples) to calculate sensitivity, specificity, and overall agreement metrics with 95% confidence intervals.

Substantial equivalence argument

NEAT and EnsoSleep perform equivalently for automated sleep staging from EEG, with differences in individual sleep stage accuracy (1-7%) that fall within expected human rater variability. Although NEAT excels at Wake, N1, and N3 classification while EnsoSleep is better at REM and N2, both devices achieve clinically comparable results. The functional limitation that NEAT lacks leg movement and apnea detection does not affect the core indication of sleep stage identification, making it substantially equivalent for its narrower, focused indication.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →